Back to first-pass browser

First-pass extracted concept

neuronal hyperexcitability in Alzheimer's disease

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This concept captures the aberrant increase in cortical and hippocampal activity discussed as an early Alzheimer’s disease phenotype. The review positions it as a central systems-level readout of disease progression.

Source 1DOIPubMed

What problem it solves

It offers a potentially earlier and mechanistically informative phenotype than end-stage neurodegeneration alone. The review argues it could help improve diagnosis and treatment development.

Source 1DOIPubMed

What it does not solve

The abstract does not establish a single causal mechanism for hyperexcitability. It also indicates that activity changes evolve over disease course, later shifting toward hypoactivity.

Source 1DOIPubMed

Alternatives

The review contrasts early hyperactivity with later hypoactivity as another disease-stage activity state rather than a separate tool or method.

Source 1DOIPubMed

Evidence Snippets

Clinical studies have shown that cortical and hippocampal hyperactivity are a feature shared by patients in the early stages of disease, progressing to hypoactivity during later stages of neurodegeneration.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1disease trajectorysupports2022Source 1DOIPubMed

In Alzheimer’s disease, cortical and hippocampal hyperactivity is reported in early stages and progresses to hypoactivity during later neurodegeneration.

Claim 2mechanistic summarysupports2022Source 1DOIPubMed

The review summarizes multiple contributors to aberrant neuronal excitability in Alzheimer’s disease, including abnormal intracellular calcium and glutamate levels, amyloid beta, tau, APOE and other genetic risk factors, and impaired inhibitory interneuron and glial function.

Claim 3translational relevancesupports2022Source 1DOIPubMed

Hyperexcitability in Alzheimer’s disease could serve as a predictive marker of cognitive dysfunction and may be leveraged to improve diagnosis and treatment development.